Temarium Temozolomide 20 mg Capsule is a prescription oncology medicine identified as containing Temozolomide 20 mg.

Temozolomide is an oral alkylating antineoplastic agent used in selected treatment regimens for malignant brain tumors.

It is an established component of treatment for glioblastoma and is also used in selected anaplastic astrocytoma treatment settings.

Temozolomide damages DNA through methylation, interfering with cancer-cell replication and survival.

It may be administered with radiotherapy or as part of subsequent chemotherapy cycles, depending on the diagnosis and prescribed oncology protocol.

The stated 20 mg capsule strength does not represent a universal patient dose.

The exact manufacturer, capsule composition, pack size, storage conditions and approved indications of Temarium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Temarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features